E5017

Anti-LPA₁, C-Terminal antibody produced in rabbit

IgG fraction of antiserum, buffered aqueous solution

• Synonym(e): Anti-EDG-2, Anti-Endothelial Cell Differentiation Gene 2
• UNSPSC Code: 12352203
• NACRES: NA.41
• MDL number: MFCD02686119

Eigenschaften

• Produktname: Anti-LPA₁, C-Terminal antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
• biological source: rabbit
• conjugate: unconjugated
• antibody form: IgG fraction of antiserum
• antibody product type: primary antibodies
• clone: polyclonal
• form: buffered aqueous solution
• mol wt: antigen ~50 kDa
• species reactivity: human, rat
• technique(s): western blot: suitable
• UniProt accession no.: Q92633
• shipped in: dry ice
• storage temp.: −20°C
• target post-translational modification: unmodified
• Quality Level: 200
• Gene Information: human ... LPAR1(1902) ; rat ... Lpar1(116744)

Beschreibung

Application

Anti-LPA₁, C-Terminal antibody produced in rabbit is suitable for western blotting at a working dilution of 1:1000 using rat brain microsomal fraction.

Biochem/physiol Actions

Lysophosphatidic acid receptor 1 (LPA1) is a protein encoded by the LPAR1 gene in humans. It is constitutively localized in the nucleus of mammalian cells and may be involved in regulating intranuclear protein phosphorylation and signalling. LPA1 is differentially expressed in androgen-insensitive and LPA-responsive cells. It is not expressed in androgen-dependent and LPA-resistant cells.Its expression is significantly higher in the cancer compared with the benign tissues and may possibly act as a drug target to interfere with progression of prostate cancer. LPA1 helps in promoting cell proliferation, survival and migration by acting on cognate G protein-coupled receptors.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Immunogen

synthetic peptide corresponding to amino acids 328-344 of human EDG-2/LPA₁.

Physical form

Solution in PBS with 0.08% sodium azide

Sicherheitshinweise

• Lagerklasse: 10 - Combustible liquids